• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清甲胎蛋白异质性作为鉴别原发性肝细胞癌和肝转移瘤的一种手段。

Serum alpha fetoprotein heterogeneity as a means of differentiating between primary hepatocellular carcinoma and hepatic secondaries.

作者信息

Buamah P K, Gibb I, Bates G, Ward A M

出版信息

Clin Chim Acta. 1984 Jun 13;139(3):313-6. doi: 10.1016/0009-8981(84)90277-8.

DOI:10.1016/0009-8981(84)90277-8
PMID:6204793
Abstract

The concanavalin A binding characteristics of serum alpha-fetoprotein (AFP) were investigated in patients with primary hepatocellular carcinoma and hepatic secondaries using affinity column chromatography and radioimmunoassay. The primary hepatocellular carcinoma (n = 21) was associated with a median concanavalin A non-reactive AFP fraction of 7.4% (range 1.6 - 18.8) while the hepatic secondaries (n = 8) had a median concanavalin A non-reactive AFP fraction of 50.7% (range 26.6 - 91.7). A simple diagnostic test for differentiating between the two groups of patients is proposed.

摘要

利用亲和柱色谱法和放射免疫分析法,对原发性肝细胞癌和肝转移癌患者血清甲胎蛋白(AFP)的伴刀豆球蛋白A结合特性进行了研究。原发性肝细胞癌患者(n = 21)中,伴刀豆球蛋白A无反应性AFP组分的中位数为7.4%(范围1.6 - 18.8),而肝转移癌患者(n = 8)中,伴刀豆球蛋白A无反应性AFP组分的中位数为50.7%(范围26.6 - 91.7)。本文提出了一种区分这两组患者的简易诊断试验。

相似文献

1
Serum alpha fetoprotein heterogeneity as a means of differentiating between primary hepatocellular carcinoma and hepatic secondaries.血清甲胎蛋白异质性作为鉴别原发性肝细胞癌和肝转移瘤的一种手段。
Clin Chim Acta. 1984 Jun 13;139(3):313-6. doi: 10.1016/0009-8981(84)90277-8.
2
Differential lectin reactivities of alpha-fetoprotein in hepatocellular carcinoma: diagnostic value when serum alpha-fetoprotein levels are slightly raised.肝细胞癌中甲胎蛋白的凝集素反应差异:血清甲胎蛋白水平轻度升高时的诊断价值
J Gastroenterol Hepatol. 1992 May-Jun;7(3):260-5. doi: 10.1111/j.1440-1746.1992.tb00976.x.
3
Concanavalin A affinity of alpha-fetoprotein. Its use in differentiating tumors.甲胎蛋白的刀豆球蛋白A亲和力。其在肿瘤鉴别中的应用。
Am J Clin Pathol. 1987 Dec;88(6):722-4. doi: 10.1093/ajcp/88.6.722.
4
Alpha-fetoprotein and its concanavalin A affinity in acute exacerbation of chronic hepatitis B.慢性乙型肝炎急性加重期的甲胎蛋白及其伴刀豆球蛋白A亲和力
Am J Gastroenterol. 1989 Jan;84(1):46-8.
5
Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy.肝细胞癌患者化疗期间血清甲胎蛋白异质性的系列变化
Cancer Chemother Pharmacol. 1986;17(2):182-4. doi: 10.1007/BF00306751.
6
Diagnosis of hepatocellular carcinoma by concanavalin A affinity electrophoresis of serum alpha-fetoprotein.通过血清甲胎蛋白的伴刀豆球蛋白A亲和电泳诊断肝细胞癌
Cancer. 1995 Oct 1;76(7):1139-44. doi: 10.1002/1097-0142(19951001)76:7<1139::aid-cncr2820760707>3.0.co;2-w.
7
Differential reactivity of alpha-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma.甲胎蛋白与凝集素的差异反应性及其在肝细胞癌诊断中的应用评估
Gan. 1984 Sep;75(9):809-15.
8
Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma.用放射免疫分析法测定甲胎蛋白浓度以诊断和排除肝细胞癌。
Br Med J. 1978 Sep 2;2(6138):661-3. doi: 10.1136/bmj.2.6138.661.
9
Clinical relevance of alphafetoprotein microheterogeneity in alphafetoprotein-secreting tumors.甲胎蛋白分泌性肿瘤中甲胎蛋白微异质性的临床相关性。
Cancer Detect Prev. 1994;18(6):447-54.
10
Affinity chromatography used in distinguishing alpha-fetoprotein in serum from patients with tumors of hepatic parenchyma and of germ cells.亲和层析法用于区分肝实质肿瘤和生殖细胞肿瘤患者血清中的甲胎蛋白。
Clin Chem. 1984 Jul;30(7):1257-8.

引用本文的文献

1
Serum profile of low molecular weight fucosylated glycoproteins for early diagnosis of hepatocellular carcinoma.用于肝细胞癌早期诊断的低分子量岩藻糖基化糖蛋白血清谱
Oncol Lett. 2020 Aug;20(2):1597-1606. doi: 10.3892/ol.2020.11727. Epub 2020 Jun 11.
2
Surrogate markers of efficacy for medical treatment of viral hepatitis.病毒性肝炎药物治疗疗效的替代标志物。
Biotechnol Healthc. 2004 Oct;1(5):42-8.
3
Tumour markers: An overview.肿瘤标志物:概述
Indian J Clin Biochem. 2007 Sep;22(2):17-31. doi: 10.1007/BF02913308.
4
Unique and differential protein signatures within the mononuclear cells of HIV-1 and HCV mono-infected and co-infected patients.HIV-1 和 HCV 单感染及合并感染患者单核细胞内独特和差异的蛋白质特征。
Clin Proteomics. 2012 Sep 7;9(1):11. doi: 10.1186/1559-0275-9-11.
5
Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma.基于糖蛋白捕获的无标记方法的开发,用于高通量筛选肝癌中的差异糖蛋白。
Mol Cell Proteomics. 2011 Jul;10(7):M110.006445. doi: 10.1074/mcp.M110.006445. Epub 2011 Apr 7.
6
Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients.肝炎患者中甲胎蛋白糖链分支改变和唾液酸的差异表达。
Glycoconj J. 2011 Jan;28(1):1-9. doi: 10.1007/s10719-010-9316-z. Epub 2010 Dec 14.
7
Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma.岩藻糖基化糖蛋白作为原发性肝细胞癌生物标志物的鉴定与开发
J Proteome Res. 2009 Feb;8(2):595-602. doi: 10.1021/pr800752c.
8
Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.利用靶向糖蛋白质组学鉴定与土拨鼠和人类肝癌相关的血清糖蛋白。
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):779-84. doi: 10.1073/pnas.0408928102. Epub 2005 Jan 10.
9
Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy.肝细胞癌患者化疗期间血清甲胎蛋白异质性的系列变化
Cancer Chemother Pharmacol. 1986;17(2):182-4. doi: 10.1007/BF00306751.